Analystreport

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) was downgraded by analysts at Roth Capital from a "buy" rating to a "neutral" rating.

Catalyst Pharmaceuticals, Inc.  (CPRX) 
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.catalystpharma.com